Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
15.06
-1.55 (-9.31%)
At close: Mar 17, 2026, 4:00 PM EDT
15.23
+0.18 (1.16%)
Pre-market: Mar 18, 2026, 9:05 AM EDT
Olema Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts that cover Olema Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $42.25, which forecasts a 180.64% increase in the stock price over the next year. The lowest target is $27 and the highest is $62.
Price Target: $42.25 (+180.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Olema Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $38 → $27 | Strong Buy | Maintains | $38 → $27 | +79.34% | Mar 18, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $60 → $62 | Strong Buy | Maintains | $60 → $62 | +311.82% | Mar 17, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | +152.41% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +152.41% | Mar 9, 2026 |
| Stifel | Stifel | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +218.83% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
6.36M
Revenue Next Year
28.44M
from 6.36M
Increased by 347.28%
EPS This Year
-2.31
from -1.87
EPS Next Year
-2.62
from -2.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 58.9M | 52.5M | |||
| Avg | 6.4M | 28.4M | |||
| Low | n/a | 8.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 725.7% | |||
| Avg | - | 347.3% | |||
| Low | - | 31.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.88 | -1.97 | |||
| Avg | -2.31 | -2.62 | |||
| Low | -2.66 | -3.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.